Class 1 UM is associated with upregulation of PReferentially expressed Antigen in MElanoma (PRAME), and class 2 UM mutations are associated with mutations or biallelic inactivation of BRCA1 (breast cancer type 1 susceptibility protein)-associated protein 1 (BAP1) [5–8]. Here, PRAME is linked to melanoma.